These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 27052153)

  • 21. Early diabetic complications in a population of young patients with type 1 diabetes mellitus despite intensive treatment.
    Nordwall M; Hyllienmark L; Ludvigsson J
    J Pediatr Endocrinol Metab; 2006 Jan; 19(1):45-54. PubMed ID: 16509528
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Disease management program (DMP) diabetes mellitus: simulation of therapeutic results of different guidelines. A new diabetes mellitus model (DMM)].
    Hauner H; Maxion-Bergemann S; Müller E; Schulz M; Huppertz E; Bergemann R
    Dtsch Med Wochenschr; 2003 May; 128(21):1167-72. PubMed ID: 12761689
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment intensification without improved HbA1c levels in children and adolescents with Type 1 diabetes mellitus.
    Sildorf SM; Hertel NT; Thomsen J; Fredheim S; Hastrup H; Pipper C; Hertz B; Svensson J;
    Diabet Med; 2016 Apr; 33(4):515-22. PubMed ID: 26333180
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [What glycemic control can be achieved in young diabetics without residual secretion of endogenous insulin? What is the frequency of severe hypoglycemia and subclinical complications?].
    Dorchy H
    Arch Pediatr; 1994 Nov; 1(11):970-81. PubMed ID: 7834046
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The importance of low HbA1c during childhood on glycaemic control in adulthood and the risk of late complications.
    Samuelsson U; Anderzen J; Åkesson K; Hanberger L
    Acta Paediatr; 2021 Apr; 110(4):1264-1272. PubMed ID: 32978990
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Eating patterns in adolescents with type 1 diabetes: Associations with metabolic control, insulin omission, and eating disorder pathology.
    Wisting L; Reas DL; Bang L; Skrivarhaug T; Dahl-Jørgensen K; Rø Ø
    Appetite; 2017 Jul; 114():226-231. PubMed ID: 28351671
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The risk for diabetic nephropathy is low in young adults in a 17-year follow-up from the Diabetes Incidence Study in Sweden (DISS). Older age and higher BMI at diabetes onset can be important risk factors.
    Svensson MK; Tyrberg M; Nyström L; Arnqvist HJ; Bolinder J; Östman J; Gudbjörnsdottir S; Landin-Olsson M; Eriksson JW
    Diabetes Metab Res Rev; 2015 Feb; 31(2):138-46. PubMed ID: 25044633
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Type 1 diabetes during adolescence: International comparison between Germany, Austria, and Sweden.
    Hanberger L; Samuelsson U; Holl RW; Fröhlich-Reiterer E; Åkesson K; Hofer S
    Pediatr Diabetes; 2018 May; 19(3):506-511. PubMed ID: 28940551
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metabolic control and complications in Italian people with diabetes treated with continuous subcutaneous insulin infusion.
    Lepore G; Bonfanti R; Bozzetto L; Di Blasi V; Girelli A; Grassi G; Iafusco D; Laviola L; Rabbone I; Schiaffini R; Bruttomesso D;
    Nutr Metab Cardiovasc Dis; 2018 Apr; 28(4):335-342. PubMed ID: 29428572
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vascular endothelial growth factor (VEGF) in children, adolescents and young adults with Type 1 diabetes mellitus: relation to glycaemic control and microvascular complications.
    Chiarelli F; Spagnoli A; Basciani F; Tumini S; Mezzetti A; Cipollone F; Cuccurullo F; Morgese G; Verrotti A
    Diabet Med; 2000 Sep; 17(9):650-6. PubMed ID: 11051284
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Contrasting the clinical care and outcomes of 2,622 children with type 1 diabetes less than 6 years of age in the United States T1D Exchange and German/Austrian DPV registries.
    Maahs DM; Hermann JM; DuBose SN; Miller KM; Heidtmann B; DiMeglio LA; Rami-Merhar B; Beck RW; Schober E; Tamborlane WV; Kapellen TM; Holl RW; ;
    Diabetologia; 2014 Aug; 57(8):1578-85. PubMed ID: 24893863
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sex differences over time for glycemic control, pump use and insulin dose in patients aged 10-40 years with type 1 diabetes: a diabetes registry study.
    Boettcher C; Tittel SR; Meissner T; Gohlke B; Stachow R; Dost A; Wunderlich S; Lowak I; Lanzinger S
    BMJ Open Diabetes Res Care; 2021 Dec; 9(2):. PubMed ID: 34969693
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of deprivation, ethnicity, and insulin pump therapy on developmental trajectories of diabetes control in COB type 1 diabetes.
    Viner RM; White B; Amin R; Peters C; Khanolkar A; Christie D; Hindmarsh PC
    Pediatr Diabetes; 2017 Aug; 18(5):384-391. PubMed ID: 27534520
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [A 20-year prospective follow-up study to evaluate the development of retinopathy and nephropathy after the onset of type 1 diabetes mellitus: Contribution of glycemic control and metabolic memory].
    Bolotskaya LL; Bessmertnaya EG; Shestakova MV; Shamkhalova MS; Nikankina LV; Ilyin AV; Glek IS; Zolotukhin AV; Dedov II
    Ter Arkh; 2017; 89(10):17-21. PubMed ID: 29171465
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relationship of glycaemic control and hypoglycaemic episodes to 4-year cardiovascular outcomes in people with type 2 diabetes starting insulin.
    Freemantle N; Danchin N; Calvi-Gries F; Vincent M; Home PD
    Diabetes Obes Metab; 2016 Feb; 18(2):152-8. PubMed ID: 26511332
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Early increase in HbA1c trajectory predicts development of severe microangiopathy in patients with type 1 diabetes: the VISS study.
    Arnqvist HJ; Ludvigsson J; Nordwall M
    BMJ Open Diabetes Res Care; 2024 May; 12(3):. PubMed ID: 38719508
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of 4 years subcutaneous insulin infusion treatment on albuminuria, kidney function and HbA1c compared with multiple daily injections: a longitudinal follow-up study.
    Rosenlund S; Hansen TW; Andersen S; Rossing P
    Diabet Med; 2015 Nov; 32(11):1445-52. PubMed ID: 26331364
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk factors for necrobiosis lipoidica in Type 1 diabetes mellitus.
    Hammer E; Lilienthal E; Hofer SE; Schulz S; Bollow E; Holl RW;
    Diabet Med; 2017 Jan; 34(1):86-92. PubMed ID: 27101431
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Beneficial effects of intensive therapy of diabetes during adolescence: outcomes after the conclusion of the Diabetes Control and Complications Trial (DCCT).
    White NH; Cleary PA; Dahms W; Goldstein D; Malone J; Tamborlane WV;
    J Pediatr; 2001 Dec; 139(6):804-12. PubMed ID: 11743505
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epidemiology of late diabetic complications. A basis for the development and evaluation of preventive programs.
    Krolewski AS; Warram JH; Freire MB
    Endocrinol Metab Clin North Am; 1996 Jun; 25(2):217-242. PubMed ID: 8799698
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.